ARTICLE | Clinical News
Inovio preclinical data
August 12, 2013 7:00 AM UTC
In a mouse model of limb ischemia, Inovio's hypoxia-inducible factor 1 alpha ( HIF1A; HIF1-alpha) plasmid DNA therapy delivered using the company's Cellectra intradermal electroporation device led to...